LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that company management will discuss Cubist’s business activities and financial outlook at the NASDAQ OMX 30th Investor Conference in December 2013. Details are below. PRESENTER: Steve Gilman, EVP and Chief Scientific Officer EVENT: NASDAQ OMX 30th Investor Conference DATE: Tuesday, December 3, 2013 TIME: 11:55 a.m. GMT LOCATION: The Waldorf Hilton, London WEBCAST: Live audio with slide
For more information, please visit
http://www.businesswire.com/news/home/20[...]Q-OMX-30th-Investor-Conference